NasdaqCM - Nasdaq Real Time Price USD
Belite Bio, Inc (BLTE)
65.50
+0.68
+(1.05%)
As of 11:52:31 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 4 |
| Avg. Estimate | -0.39 | -0.39 | -1.71 | -1.52 |
| Low Estimate | -0.48 | -0.49 | -1.91 | -2 |
| High Estimate | -0.3 | -0.3 | -1.48 | -0.45 |
| Year Ago EPS | -0.31 | -0.28 | -1.18 | -1.71 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 4 | 5 |
| Avg. Estimate | -- | -- | -- | 5M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 25M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.3 | -0.31 | -0.37 |
| EPS Actual | -0.31 | -0.28 | -0.32 | -0.45 |
| Difference | -0.05 | 0.02 | -0.01 | -0.09 |
| Surprise % | -19.23% | 6.67% | -4.07% | -23.29% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.39 | -0.39 | -1.71 | -1.52 |
| 7 Days Ago | -0.36 | -0.36 | -1.12 | -1.41 |
| 30 Days Ago | -0.36 | -0.36 | -1.12 | -1.41 |
| 60 Days Ago | -0.33 | -0.34 | -1.41 | -1.21 |
| 90 Days Ago | -0.35 | -0.31 | -0.99 | -0.12 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | 2 | -- |
| Down Last 30 Days | 2 | -- | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLTE | -25.81% | -40.18% | -45.20% | 10.99% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/15/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2025 |
| Reiterates | Benchmark: Buy to Buy | 3/26/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/18/2025 |
| Maintains | Benchmark: Buy to Buy | 1/21/2025 |
Related Tickers
NUVL Nuvalent, Inc.
78.33
+0.19%
6696.TWO Lin BioScience, Inc.
137.00
0.00%
ACLX Arcellx, Inc.
66.49
+2.06%
IMVT Immunovant, Inc.
15.62
+1.17%
7832.TWO Intelligene
12.70
+0.79%
AKRO Akero Therapeutics, Inc.
52.92
+2.54%
PCVX Vaxcyte, Inc.
34.97
+0.92%
SRRK Scholar Rock Holding Corporation
31.49
+1.76%
MRUS Merus N.V.
57.71
-7.55%
APGE Apogee Therapeutics, Inc.
37.70
+1.67%